Skip to main content
. 2021 Feb 6;13(2):226. doi: 10.3390/pharmaceutics13020226

Figure 10.

Figure 10

Viability of the CACO cells treated with different concentrations of 5-Fu and 5-FuCrNPs determined by the MTT assay (a). Flow cytometry analysis showing the frequency of apoptotic cells treated with 5-Fu (b), CrNPs (c), and 5-FuCrNPs (d).